My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1693

    1.

    The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

    Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

    Diabetes Care. 2002 Jan;25(1):9-15.PMID: 11772894 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.

    Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles WH, Gallina DL, El-Kebbi IM, Ziemer DC, Ernst KL, Dunbar VG, Phillips LS.

    Diabetes Care. 2000 Mar;23(3):319-24.PMID: 10868858 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

    Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

    Diabetes Care. 2001 Jul;24(7):1167-74.PMID: 11423497 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levels.

    Olansky L, Marchetti A, Lau H.

    Clin Ther. 2003;25 Suppl B:B64-80. Review.PMID: 14553867 [PubMed - indexed for MEDLINE]Related articles

    5.

    Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.

    Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group.

    Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65.PMID: 17283301 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.

    Dailey GE 3rd, Mohideen P, Fiedorek FT.

    Clin Ther. 2002 Sep;24(9):1426-38.PMID: 12380634 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.

    King AB, Armstrong DU.

    Diabetes Technol Ther. 2002;4(2):145-51.PMID: 12079617 [PubMed - indexed for MEDLINE]Related articles

    8.

    The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.

    Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K.

    Diabetes Care. 1997 May;20(5):745-52.PMID: 9135936 [PubMed - indexed for MEDLINE]Related articles

    9.

    The long-term effects of rosiglitazone on serum lipid concentrations and body weight.

    Shim WS, Do MY, Kim SK, Kim HJ, Hur KY, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS.

    Clin Endocrinol (Oxf). 2006 Oct;65(4):453-9.PMID: 16984237 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.

    Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.

    Diabetes Care. 1994 May;17(5):397-404.PMID: 8062606 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.

    Ahmad Khan H.

    Acta Diabetol. 2007 Dec;44(4):193-200. Epub 2007 Sep 1.PMID: 17786383 [PubMed - indexed for MEDLINE]Related articles

    13.

    Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

    Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

    Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes.

    El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS.

    Arch Intern Med. 2003 Jan 13;163(1):69-75.PMID: 12523919 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.

    Ybarra J, James RW, Makoundou V, Bioletto S, Golay A.

    Diabetes Metab. 2001 Dec;27(6):701-8.PMID: 11852380 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

    Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

    Clin Ther. 2004 May;26(5):744-54.PMID: 15220018 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

    Pérez A, Wägner AM, Carreras G, Giménez G, Sánchez-Quesada JL, Rigla M, Gómez-Gerique JA, Pou JM, de Leiva A.

    Arch Intern Med. 2000 Oct 9;160(18):2756-62.PMID: 11025785 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes.

    Cook CB, Ziemer DC, El-Kebbi IM, Gallina DL, Dunbar VG, Ernst KL, Phillips LS.

    Diabetes Care. 1999 Sep;22(9):1494-500.PMID: 10480515 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

    Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

    Diabetes Care. 1995 Aug;18(8):1113-23.PMID: 7587846 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

    Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

    Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971.. PMID: 12032111 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity